Honeywell opens Munich Technical Centre

Published: 20-Jun-2011
Finance Analysis

Will provide German customers with support, training and centralised repair and maintenance services

Honeywell has opened a new Technical Centre in Munich, Germany to provide gas detection customers in the country with additional local services such as customer support, a training centre, and centralised repair and equipment maintenance services. The site will also house project engineering and r&d teams.

Ingo Löffler, Honeywell’s sales leader Semi/Hi-Tech EMEAI, said: ‘The new Technical Centre will enable us to deliver a more effective service, enhance our customer support and provide an easy to access training location for German and European customers. The Project Engineering and R&D teams on-site will also help us to develop tailor-made systems to specifically meet the needs of German customers.’

The 1,800m2 Technical Centre will include three fully equipped training suites, where customers can gain knowledge of a wide range of topics from the basics of gas detection to master classes on topics such as product certification.

See more

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

Read more
The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software

Trending Articles

  1. AstraZeneca to expand Virginia manufacturing facility with $4.5bn investment, creating 3600 jobs AstraZeneca will develop a state-of-the-art manufacturing facility in Albemarle County, Virginia, producing a broader range of medicines, including weight management, metabolic and cancer therapies
  2. AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the nation’s biopharma innovation leadership
  3. Optimised fittings for microfluidic systems Miniature flat-bottom ports combine convenience and performance for precise fluid control
  4. Gerresheimer adjusts 2025 guidance amid slower market growth Transformation program launched to boost performance and free cash flow
  5. Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable dual GLP-1/GIP receptor agonist with potentially best-in-category weight loss

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software
Analysis

When is gas potentially fatal?

Following a move to new premises with custom-built service facilities, Ashtead Technology has extended its RAE/Honeywell servicing capabilities to help customers ensure the accuracy and reliability of their gas detection activities
Manufacturing

Honeywell launches double-certified reference materials for calibration of laboratory instruments

New generation of Hydranal accredited under ISO Guide 34 simplifies calibration of instruments for research laboratories
Research & Development

Lab Innovations adds major names to its show stopping exhibitor line-up

Lab Innovations 2016 welcomes back an array of leading industry suppliers from across the UK, spanning the entire laboratory spectrum
Ingredients

Honeywell completes purchase of Sigma-Aldrich's Research Chemicals Business

Adds Fluka, Hydranal and Chromasolv brands to portfolio
Regulatory

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Drug Delivery

Optimised fittings for microfluidic systems

Miniature flat-bottom ports combine convenience and performance for precise fluid control
Subscribe now